IP Library Granted Patent US 11,000,208
Granted Patent B2
US 11,000,208 · App. 16/355,341 · Granted May 11, 2021

Screening devices and methods for obstructive sleep apnea therapy

Inventors: Wondimeneh Tesfayesus (St. Paul, MN); Stephen L. Bolea (Watertown, MN); Peter R. Eastwood (Western Australia, AU); David R. Hillman (Western Australia, AU)
Assignee: LivaNova USA, Inc.
A61B5/0826A61B1/233A61B1/267A61B5/4552A61N1/0551A61N1/3601A61N1/3611A61N1/36139A61N1/0519
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,000,208
App. No.
16/355,341
Granted
May 11, 2021
Kind
B2
Abstract

Devices and methods for treating obstructive sleep apnea by first performing an assessment of the patient that involves observing the patient's upper airway during a tongue protrusion maneuver. The assessment may, for example, be done using endoscopy to observe the upper airway while the patient is awake in the supine position. An adequate response of the upper airway during the tongue protrusion maneuver is indicative of likely therapeutic success with hypoglossal nerve stimulation, and may be used for making clinical decisions. The principles of the present invention may be applied to other therapeutic interventions for OSA involving the upper airway.

Claims (39)

1. A method of assessing a patient's suitability for an upper airway stimulation therapy, the method comprising:

inserting a visualization device into the patient's upper airway;

measuring a size of the patient's upper airway during a tongue protrusion maneuver; and

generating an indication of suitability for the upper airway stimulation therapy based on the measured size of the patient's upper airway.

2. The method of claim 1 , wherein measuring the size of the patient's upper airway comprises measuring the size of the patient's upper airway using a qualitative scale.

3. The method of claim 2 , wherein the qualitative scale is a visual analog scale.

4. The method of claim 1 , wherein measuring the size of the patient's upper airway comprises measuring the size of the patient's upper airway using a quantitative scale.

5. The method of claim 4 , wherein the quantitative scale includes at least one of a pixel count of captured images representative of a cross-sectional area of the patient's upper airway, a linear dimension of the patient's upper airway, or a measure of a circumference of the patient's upper airway.

6. The method of claim 1 , wherein generating the indication of suitability for the upper airway stimulation therapy comprises comparing the measured size of the patient's upper airway to a threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the measured size meeting or exceeding the threshold.

7. The method of claim 6 , wherein the threshold is one of an absolute value or a relative value.

8. The method of claim 7 , wherein the threshold is a relative value of the measured size of the patient's upper airway relative to a size of an anatomical landmark of the patient.

9. The method of claim 1 , further comprising measuring the size of the patient's upper airway with the tongue at rest; and

wherein generating the indication of suitability for the upper airway stimulation therapy comprises:

taking a difference between the measured size of the patient's upper airway during the tongue protrusion maneuver and the measured size of the patient's upper airway with the tongue at rest; and

comparing the difference to a threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the difference meeting or exceeding the threshold.

10. The method of claim 9 , wherein the threshold is one of a percentage increase in size of the patient's upper airway, an absolute value, or a relative value.

11. The method of claim 1 , further comprising measuring the size of the patient's upper airway with the tongue at rest; and

wherein generating the indication of suitability for the upper airway stimulation therapy comprises:

taking a difference between the measured size of the of the patient's upper airway during the tongue protrusion maneuver and the measured size of the patient's upper airway with the tongue at rest; and

comparing the measured size of the patient's upper airway during the tongue protrusion maneuver to a first threshold and comparing the difference to a second threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the measured size of the patient's upper airway during the tongue protrusion maneuver meeting or exceeding the first threshold and the difference meeting or exceeding the second threshold.

12. The method of claim 11 , wherein the first threshold is one of an absolute value or a relative value, and wherein the second threshold is one of a percentage increase in size of the patient's upper airway, an absolute value, or a relative value.

13. The method of claim 1 , further comprising, responsive to the indication indicating the patient is suitable for the upper airway stimulation therapy, applying stimulation to the patient's upper airway using an implantable neurostimulator.

14. A method of assessing a patient's suitability for an upper airway stimulation therapy, the method comprising:

recording, by an imaging device, a patient's upper airway during a tongue protrusion maneuver;

generating a record of the patient's upper airway, the record including a characterization of a size of the patient's upper airway during the tongue protrusion maneuver;

generating an indication of suitability for the upper airway stimulation therapy based on the characterization of the size of the patient's upper airway during the tongue protrusion maneuver; and

responsive to the indication indicating the patient is suitable for the upper airway stimulation therapy, applying stimulation to the patient's upper airway using an implantable neurostimulator.

15. The method of claim 14 , wherein generating the record of the patient's upper airway comprises receiving a value on a qualitative scale characterizing the size of the patient's upper airway during the tongue protrusion maneuver.

16. The method of claim 14 , wherein generating the record of the patient's upper airway comprises measuring the size of the patient's upper airway during the tongue protrusion maneuver using a quantitative scale, the characterization comprising the measured size of the patient's upper airway during the tongue protrusion maneuver.

17. The method of claim 16 , wherein the quantitative scale includes at least one of a pixel count of captured images representative of a cross-sectional area of the patient's upper airway, a linear dimension of the patient's upper airway, or a measure of a circumference of the patient's upper airway.

18. The method of claim 14 , wherein generating the indication of suitability for the upper airway stimulation therapy comprises comparing the characterization of the patient's upper airway to a threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the characterization of the patient's upper airway meeting or exceeding the threshold.

19. The method of claim 14 , further comprising recording, by the imaging device, the patient's upper airway with the tongue at rest, wherein the record of the patient's upper airway further includes a characterization of the size of the patient's upper airway with the tongue at rest; and

wherein generating the indication of suitability for the upper airway stimulation therapy comprises:

taking a difference between the characterization of the size of the patient's upper airway during the tongue protrusion maneuver and the characterization of the patient's upper airway with the tongue at rest; and

comparing the difference to a threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the difference meeting or exceeding the threshold.

20. The method of claim 14 , further comprising recording, by the imaging device, the patient's upper airway with the tongue at rest, wherein the record of the patient's upper airway further includes a characterization of the size of the patient's upper airway with the tongue at rest; and

wherein generating the indication of suitability for the upper airway stimulation therapy comprises:

taking a difference between the characterization of the size of the patient's upper airway during the tongue protrusion maneuver and the characterization of the patient's upper airway with the tongue at rest; and

comparing the characterization of the patient's upper airway during the tongue protrusion maneuver to a first threshold and comparing the difference to a second threshold, the indication indicating the patient is suitable for the upper airway stimulation therapy based on the characterization of the patient's upper airway during the tongue protrusion maneuver meeting or exceeding the first threshold and the difference meeting or exceeding the second threshold.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →